Invention 2019-084...
TORONTO, Feb. 4, 2021 /CNW/ - Diamond Therapeutics Inc. ("Diamond"), a leading psychedelic drug development company focused on low-dose therapies for mental health, has entered into an agreement...
Business Snapshot...
Invention 2018-040...
Invention 2018-064...
Sent on behalf of Martha Crago, Vice-Principal (Research and Innovation)...
Invention 2019-099...
This is a reminder to all principal investigators to complete their Canada Research Continuity Emergency Fund Stage 3 claims as soon as possible.
Invention 2019-085...